11 March 2026
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
11 March 2026
Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.
11 March 2026
The NHI corruption risks are exposed in light of bribery cases, raising concerns for the future of healthcare in South Africa.
10 March 2026
Understand the current status of NHI preparations in South Africa, including government strategies and ongoing legal challenges.
10 March 2026
Discover how AfroCentric results indicate strong revenue growth while navigating a R1.27bn loss through strategic changes.
8 March 2026
Discover the impact of Huawei AI in healthcare, improving diagnosis, treatment, and patient outcomes across the industry.
7 March 2026
Explore the latest Discovery Vitality results revealing a 41% profit surge driven by AI and unified global operations.
7 March 2026
Aspen Pharmacare Debt-Free marks a pivotal moment in its history as it shifts focus toward GLP-1 injectables like semaglutide.
6 March 2026
Dive into the Global Fund fraud case: Health director-general Sandile Buthelezi faces charges of fraud and theft.
6 March 2026
Learn how Discovery’s interim results reflect a 22% increase in normalised profit, demonstrating resilience in a fluctuating market.
6 March 2026
Join the discussion on local pharmaceutical manufacturing versus cost in South Africa's contentious R15.5bn AIDS drug tender situation.
6 March 2026
Learn how medical tax credits were increased as the Treasury rejects the NHI funding proposal, protecting the middle class.